The effects of chondroitin sulfate samples with decreasing charge densities, different 4-sulfate/6-sulfate ratios, and various molecular masses on Cu2+-induced oxidation of human low-density lipoprotein (LDL) were evaluated by monitoring conjugated diene formation and the tryptophan fluorescence kinetics. Low-sulfated chondroitin sulfate (CS) from beef trachea had a very strong protective antioxidant effect. Quite similar behavior was observed for CS from pig trachea, and a fructose-containing polysaccharide with a chondroitin backbone from Escherichia coli was also strongly protective as to LDL oxidation. CS samples with decreasing charge densities proved effective in inhibiting LDL oxidation.
A totally desulfated sample still exhibited a great capacity to protect LDL against oxidation.
CS-4-sulfate samples (sulfate to carboxyl ratio of 0.62, about 65% 4-sulfate groups and 5% 6-sulfate groups) retained great ability to inhibit the Cult-mediated human LDL oxidation.
CS fractions with different molecular masses were examined as possible inhibitors of LDL oxidation. Samples with molecular masses lower than about 8,570 (13-15 disaccharide units) were unable to protect human LDL from Cult-induced oxidation.
Similar results were obtained on studying the degradation of tryptophan residues of the LDL protein moiety resulting from Cull complexation through amino acid residues. A low-sulfated CS (sulfate to carboxyl ratio of 0.41, a molecular mass of about 15,600) having effective anti-oxidant properties as to metal-induced LDL oxidation was isolated from normal human plasma. The protective capacity as to Cult-mediated LDL oxidation of CS is discussed in relation to its structure, also considering the physiological rnle of plasma CS in relation to factors that can alter its properties.
Oxidatively modified low-density lipoproteins (LDLs) play a critical role in atherogenesis. LDL that has been oxidized by exposure to trace metals (Cu2+ and Feet), lipoxygenase or endothelial cells is rapidly taken up by macrophages and smooth muscle cells. This process, independent of the intracellular cholesterol level, can lead to the formation of foam cells, with possible build up of atherosclerotic plaques (1) (2) (3) . Moreover, oxidized LDL may cause thrombosis, acting on both endothelial cells and platelets (4) . Agents that decrease the oxidation of LDL in vitro, such as ascorbate or probucol, exert a marked antiatherogenic effect in experimental animals (5) .
The atherosclerotic arterial wall contains increased levels of copper and iron ions, which contribute to the 1 oxidation of LDL (1) through the generation of free radi cals. In this compartment, LDL may also interact with proteoglycans that are formed through various glycos aminoglycan (GAG) chains, mainly chondroitin sulfate (CS), dermatan sulfate, and heparan sulfate (6, 7) . The modification in the Cult-mediated oxidation kinetics of LDL by heparin (8) and CS (9) was recently shown, and although several studies revealed a specific LDL proteinGAGs interaction (10, 11) , few data are available on the effect of polysaccharides with various structures and properties on ions-catalyzed LDL oxidation. GAGs consist of alternating copolymers of uronic acids and amino sugars, and they are very heterogeneous polysaccharides in terms of relative molecular mass, charge density, and physico-chemical properties (3, 12) . The heterogeneity of the backbone of sulfated GAGs is increased by the presence of sulfate groups in varying amounts and 0-linked in different positions. On this basis, we investigated the capacities of various natural CS puri fied from animal tissues and of modified polysaccharides to alter the Cu2+-mediated oxidation of human LDL. Therefore, we studied the effects of CS species desulfated to different extents and fractions with decreasing molecular masses in an attempt to determine the properties and characteristics that this GAG must possess to effectively inhibit human LDL oxidation in vitro. This last point could be of some importance in clinical applications as transition metals play a role at several levels of the lipid oxidation of LDL in addition to the initial stages (13) , and lipid peroxidation is inhibited by iron chelation (14) . Furthermore, we evaluated the capacity of a low-sulfated CS isolated from normal human plasma to protect against LDL oxidation. This is of importance for understanding some of the complex factors involved in protection against LDL oxidation in vivo under physiological and pathological conditions. As an experimental model, highly reproducible LDL oxidation mediated by Cu2+ was used (15) , and several characteristic indices were determined. The effects of CS and derivatives on tryptophan residues of the protein moiety of LDL during oxidation were also investigated. that human plasma low-sulfated CS has effective antiox idant properties. The capacity of low-sulfated human plasma CS to protect LDL against Cull -induced oxidation confirms the relative importance of the polysaccharide charge density in LDL oxidation kinetics. Effects of CS Samples on LDL-Tryptophan Fluorescence Kinetics- Figure  6 shows the effects of natural CS, a totally desulfated CS, two samples with different molecular masses (11, 380 and 8,570) , and normal human plasmaderived CS on copper-induced tryptophan quenching. The kinetics of tryptophan fluorescence decrease during coppermediated LDL oxidation, and the natural CS, desulfated CS, fraction with a molecular mass of 11,380, and plasma derived GAG are able to reduce tryptophan quenching. On the contrary, the CS fraction with a molecular mass of 8,570 is ineffective. Table  III ). (31) . The relative content of chondroitin-4-sulfate/chondroi tin-6-sulfate isomers in the human aorta varies with age, with a decrease in the 4-sulfate/6-sulfate ratio (32) . The loss of the chondroitin-4-sulfate isomer and the concomi tant increase in chondroitin-6-sulfate is even more pro nounced in atherosclerotic lesions (32) . We suggest that modifications of the numbers and positions of sulfate groups of the CS chains of human aorta PGs, and then of the 4-sulfate to 6-sulfate ratio and charge density of CS are not factors responsible for the greater susceptibility of LDL to oxidation. In light of the results presented here, we assume that a decrease in the CS content or a reduced CS molecular mass (approx. lower than 8,600, 13-15 disaccharide units) might contribute to the inability of CS to protect LDL from oxidation, and to the deposition of oxidatively modified human LDL in the extracellular matrix of the arterial intima, predisposing to atherosclerosis (33) . Upon stimula tion with bacterial antigens, polymorphonuclear leukocytes produce reactive oxygen species, such as the superoxide radical anion and hydrogen peroxide, which further interact in the presence of transition metal ions to produce hydroxyl radicals (34) . Many of these reactive oxygen species are unable to discriminate between host and pathogen macromolecules, resulting in losses of structural integrity and function of tissues (34) . CS present in connective tissues is depolymerized by oxygen-derived species (35) , and CSs from different sources are degraded by a free-radical process mediated by ions (36, 37) with marginal desulfa tion. These considerations strengthen the view that free radicals may contribute to the oxidation of LDL, acting as direct agents producing oxidation, and also degrading CS, thus altering the ability of this polysaccharide to protect LDL from further oxidation.
